Network meta-analysis of CAR T-Cell therapy for the treatment of 3L+ R/R LBCL after using published comparative studies.

Olalekan O OluwoleSattva S NeelapuMarkqayne D RayEve H Limbrick-OldfieldSally W WadeSteve KantersAnik R PatelFrederick L Locke

Published in: Expert review of anticancer therapy (2024)

We highlight important differences in clinical outcomes between CAR T-cell therapies. Axi-cel demonstrated improved overall survival compared to tisa-cel and liso-cel, and both axi-cel and liso-cel showed higher response rates compared to tisa-cel.

Keyphrases

cell therapy
systematic review
stem cells
meta analyses
case control
mesenchymal stem cells
replacement therapy
free survival